ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $29,000 | -81.0% | 46,997 | -60.0% | 0.00% | – |
Q3 2018 | $153,000 | +66.3% | 117,617 | +74.1% | 0.00% | – |
Q2 2018 | $92,000 | -5.2% | 67,543 | +57.8% | 0.00% | – |
Q4 2017 | $97,000 | +162.2% | 42,807 | +289.2% | 0.00% | – |
Q3 2017 | $37,000 | -39.3% | 11,000 | -36.2% | 0.00% | – |
Q2 2017 | $61,000 | -37.1% | 17,251 | -18.2% | 0.00% | – |
Q2 2015 | $97,000 | – | 21,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 5,292,156 | $7,674,000 | 1.12% |
Northeast Financial Consultants Inc | 732,265 | $1,061,000 | 0.36% |
Family Management Corp | 10,424 | $15,000 | 0.01% |
AJ WEALTH STRATEGIES, LLC | 15,000 | $22,000 | 0.01% |
Poehling Capital Management, INC. | 3,302 | $5,000 | 0.00% |
A.R.T. Advisors, LLC | 48,692 | $70,000 | 0.00% |
Virtu Financial LLC | 34,383 | $50,000 | 0.00% |
Founders Capital Management | 3,000 | $4,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,854 | $220,000 | 0.00% |
BEACON INVESTMENT ADVISORY SERVICES, INC. | 10,500 | $15,000 | 0.00% |